Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...

MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The ...

Automotive enthusiasts attach special significance to the term “barn find,” applying it to rare and hidden gems that, for one reason or another, haven’t seen the light of day for years, or even ...